Valuation: Sera Prognostics, Inc.

Market Cap 8.01Cr 7.15Cr 6.64Cr 6.04Cr 11Cr 758.5Cr 12Cr 80Cr 31Cr 395.75Cr 30Cr 29Cr 1.27TCr P/E 2026 *
-3.09x
P/E 2027 * -3.79x
Enterprise Value 8.01Cr 7.15Cr 6.64Cr 6.04Cr 11Cr 758.5Cr 12Cr 80Cr 31Cr 395.75Cr 30Cr 29Cr 1.27TCr EV / Sales 2026 *
356x
EV / Sales 2027 * 41.6x
Free-Float
85.71%
Yield 2026 *
-
Yield 2027 * -
1 day-1.93%
1 week+0.50%
Current month-2.87%
1 month+2.01%
3 months-6.02%
6 months-6.88%
Current year-31.19%
1 week 2.03
Extreme 2.03
2.1
1 month 2
Extreme 2
2.21
Current year 1.56
Extreme 1.56
3.85
1 year 1.56
Extreme 1.56
3.95
3 years 1.37
Extreme 1.37
12.36
5 years 1.1
Extreme 1.1
12.36
10 years 1.1
Extreme 1.1
15.5
Manager TitleAgeSince
Chief Executive Officer 52 01/06/2023
Director of Finance/CFO 47 31/08/2026
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Chairman 74 20/04/2011
Chairman 58 08/06/2023
Director/Board Member 59 01/11/2011
Date Insider Type Main position Quantity % Market Cap. Importance
12/10/26 Sell

Chief Technology Officer

-8,024 0.0209%
10/09/26 Sell

Chief Executive Officer

-7,022 0.0182%
10/09/26 Sell

General Counsel

-2,190 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
-1.93%+0.50%-35.14%+6.28% 8.17Cr
+2.13%+6.57%+15.64%+68.20% 72TCr
+2.12%+5.94%+13.66%+66.25% 8.28TCr
+1.23%-0.24%+2.70%+141.91% 6.44TCr
+1.29%-14.25%+49.73%+894.77% 5.1TCr
+1.89%+3.89%-15.92%+2.53% 4.8TCr
+5.25%+6.11%+4.86%+84.92% 4.59TCr
+1.19%+2.22%+9.10%+26.09% 3.1TCr
+3.35%+1.02%+41.15%+62.86% 2.58TCr
+2.47%+2.76%-61.02%-58.03% 2.45TCr
Average +1.65%-0.35%+2.48%+129.58% 10.92TCr
Weighted average by Cap. +2.05%+3.05%+13.17%+104.65%

Financials

2026 *2027 *
Net sales 2L 2L 2L 2L 3L 2.13Cr 3L 22.42L 9L 1.11Cr 8L 8L 3.56Cr 19.25L 17.18L 15.97L 14.53L 27.33L 18Cr 27.82L 1.92Cr 75.06L 9.51Cr 72.24L 70.71L 30Cr
Net income -3.39Cr -3.03Cr -2.82Cr -2.56Cr -4.82Cr -321.4Cr -4.9Cr -34Cr -13Cr -167.69Cr -13Cr -12Cr -536.6Cr -2.91Cr -2.6Cr -2.41Cr -2.2Cr -4.13Cr -275.62Cr -4.21Cr -29Cr -11Cr -143.81Cr -11Cr -11Cr -460.17Cr
Net Debt - -
Projected Income Statement - Annual - Sera Prognostics, Inc.
Logo Sera Prognostics, Inc.
Sera Prognostics, Inc. is a women's health diagnostic company utilizing its proprietary proteomics and bioinformatics platform, and significant data resources to enhance maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. It has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found in blood that are accurate predictors of dynamic changes that occur during pregnancy. Its commercial product, the PreTRM test, is a validated, commercially available blood-based biomarker test to predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation that provides a prediction of the expectant mother’s risk of delivering spontaneously before 37 weeks’ gestation.
Employees
72
Date Price Change Volume
15/26/15 $2.030 -1.93% 13,300
14/26/14 $2.070 +1.47% 5,838
13/26/13 $2.040 -1.45% 4,686
12/26/12 $2.070 +1.47% 13,799
09/26/09 $2.040 +0.99% 6,298
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Sera Prognostics, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.030USD
Average target price
5.500USD
Spread / Average Target
+170.94%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Sera Prognostics, Inc.
  1. Stock Market
  2. Stocks
  3. SERA Stock